OCCUDO QUANTITATIVE STRATEGIES LP - PROTAGONIST THERAPEUTICS INC ownership

PROTAGONIST THERAPEUTICS INC's ticker is PTGX and the CUSIP is 74366E102. A total of 144 filers reported holding PROTAGONIST THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is 0.37 and the average weighting 0.3%.

Quarter-by-quarter ownership
OCCUDO QUANTITATIVE STRATEGIES LP ownership history of PROTAGONIST THERAPEUTICS INC
ValueSharesWeighting
Q4 2022$111,260
-36.8%
10,198
-51.2%
0.01%
-7.1%
Q3 2022$176,000
-83.9%
20,887
-84.9%
0.01%
-84.4%
Q2 2022$1,095,000
+98.0%
138,395
+492.4%
0.09%
+95.7%
Q1 2022$553,000
+30.7%
23,360
-2.2%
0.05%
-9.8%
Q3 2021$423,00023,8760.05%
Other shareholders
PROTAGONIST THERAPEUTICS INC shareholders Q1 2022
NameSharesValueWeighting ↓
JOHNSON & JOHNSON 2,449,183$43,400,0003.81%
BVF INC/IL 3,901,759$69,139,0002.70%
COMMODORE CAPITAL LP 498,079$8,826,0002.33%
Altium Capital Management LP 346,000$6,131,0001.61%
Twin Lakes Capital Management, LLC 139,287$2,468,0001.45%
Opaleye Management Inc. 330,222$5,852,0001.09%
EcoR1 Capital, LLC 1,443,800$25,584,0000.89%
OBERMEYER WOOD INVESTMENT COUNSEL, LLLP 776,689$13,763,0000.76%
JABODON PT CO 90,656$1,606,0000.66%
Artal Group S.A. 1,500,000$26,580,0000.60%
View complete list of PROTAGONIST THERAPEUTICS INC shareholders